NACDS is actively engaged in advocacy efforts urging Congress to support a TRICARE pilot program, which would allow Department of Defense acquisition cost parity for prescriptions obtained at retail pharmacies. The targeted efforts are underway as Congress prepares to mark up the FY2017 National Defense Authorization Act (NDAA).
NACDS has remained highly engaged in efforts to preserve pharmacy access and choice for TRICARE patients…
NACDS also opposes further pharmacy copay increases for TRICARE beneficiaries, which place a great burden on TRICARE beneficiaries—especially retirees and families of active duty military—and also severely limits their ability to receive medications and services from their neighborhood pharmacies.
This week NACDS RxIMPACT launched a grasstops campaign asking nearly 85 percent of NACDS members operating in states and districts represented by the 88 members of the House and Senate Armed Services Committees to promote TRICARE priorities, including the pilot. NACDS will also be discussing these proposals with officials from the TRICARE program, as well as the individual armed services branches.
NACDS has remained highly engaged in efforts to preserve pharmacy access and choice for TRICARE patients over the years.
More information about NACDS’ engagement on this issue can be accessed through the TRICARE tag on NACDS.org.